Crystal structure of elvitegravir Form II, C23H23ClFNO5
Journal Article
·
· Powder Diffraction
- Illinois Institute of Technology, Chicago, IL (United States); North Central College, Naperville, IL (United States)
- ICDD, Newtown Square, PA (United States)
The crystal structure of elvitegravir Form II has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Elvitegravir Form II crystallizes in space group P21 (#4) with a = 11.54842(7), b = 14.04367(5), c = 13.33333(8) Å, β = 90.0330(6)°, V = 2162.427(14) Å3, and Z = 4. The crystal structure consists of alternating layers of parallel molecules perpendicular to the b-axis. The mean planes of the oxoquinoline ring systems in molecules 1 and 2 are 1(22)-1 and -1(22)1. Between the stacks are layers of the halogenated phenyl rings. These exhibit herringbone stacking. In each molecule, the carboxylic acid group forms a strong intramolecular O–H∙∙∙O hydrogen bond to the nearby carbonyl group. The hydroxyl group of each molecule forms a strong hydrogen bond to the carbonyl group of the carboxylic acid of the other molecule. These O–H∙∙∙O hydrogen bonds link the molecules into dimers, with a graph set R2,2(18) > a > c. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®).
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423341
- Journal Information:
- Powder Diffraction, Journal Name: Powder Diffraction Journal Issue: 1 Vol. 38; ISSN 0885-7156
- Publisher:
- Cambridge University PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crystal structure of anthraquinone-2-carboxylic acid, C15H8O4
Crystal structure of oxibendazole, C12H15N3O3
Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
Journal Article
·
Sun Feb 18 19:00:00 EST 2024
· Powder Diffraction
·
OSTI ID:2581377
Crystal structure of oxibendazole, C12H15N3O3
Journal Article
·
Sun Jan 08 19:00:00 EST 2023
· Powder Diffraction
·
OSTI ID:2423349
Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
Journal Article
·
Thu Jan 26 19:00:00 EST 2023
· Powder Diffraction
·
OSTI ID:2423335